CTRI/2017/12/010848尚未招募4 期
Moderation of Naltrexone treatment response by OPRM1 gene polymorphism among patients with alcohol dependence in India - MNTRBOAD
avina Suresh0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.ICD 10 criteria for alcohol use disorder.
- •2.Alcohol use disorder male subjects between the age group 18 to 60 years.
- •3.Abstinence from alcohol and other substances for 3-7 days.
- •4.Ability to provide informed consent.
- •5. One or more relatives or significant others who are willing to encourage medication therapy, adherence and provide follow-up information if contacted by research staff.
排除标准
- •1.Major psychiatric disorder (i.e, schizophrenia, bipolar disorder, seizure disorder, alcohol induced psychotic disorder or dementia).
- •2.Advanced neurological, cardiovascular, renal, or hepatic disease; active tuberculosis or current febrile illness.
- •3.AIDS defining illness.
- •4.Significant laboratory abnormality (alanine aminotransferase/aspartate aminotransferase [ALT/AST] levels of greater than 5 times the top reference limit).
研究者
相似试验
已完成
不适用
The effect of Naltrexone, an Opiate Receptor Antagonist, on capsaicin dose-response in male Healthy volunteers (NORAH)ISRCTN35917266South Manchester University Hospital (UK)20
已完成
3 期
Study of the efficacy of naltrexone on positive and negative symptoms in schizophrenic patientsSchizophrenia.SchizophreniaIRCT201110093010N4Kermanshah University of Medical Sciences30
进行中（未招募）
1 期
To evaluate the effect of low-dose naltrexone (LDN) on pain perception and quality of life in womeEUCTR2022-000245-33-PLMedical University of Lublin300
招募中
不适用
ow Dose Naltrexone for the induction of remission in patients with mild to moderate Crohn’s Diseasethat failed conventional treatmentNL-OMON21939ZonMW122
尚未招募
2 期
ow Dose Naltrexone for the induction of remission in patients with mild to moderate Crohn*s Disease that failed conventional treatmentinflammatory bowel disease10017969Crohn's diseaseNL-OMON52463Erasmus MC, Universitair Medisch Centrum Rotterdam122